BridgeMD
New treatment option for Glaucoma
Official title The Role of Transscleral Cyclophotocoagulation in Patients Undergoing a Boston Keratoprosthesis
ClinicalTrials.gov ID: NCT04232982
What this study is testing
- What it's testing
- The Boston keratoprosthesis (KPro) is a special plastic device that is used to replace a sick cornea (transparent part of the eye, in front of the iris) in order to restore vision in patients who have failed traditional corneal transplants or have a very poor prognosis of success. Glaucoma is a chronic disease which causes optic nerve damage secondary to high pressure inside the eye and could lead to vision loss in the long term.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Adults patients
- Able to give an informed consent
- Capable of being followed during the study
- Candidate for the Boston keratoprosthesis type I
You likely can't join if
- Patients younger than 18 years old or older than 80 years old
- Unable to give an informed consent
- Participating to another treatment glaucoma study
- Patients who received a glaucoma surgery or procedure (glaucoma drainage device or TS-CPC treatment) 3 months before their initial visit.
- Unable to wear a therapeutic contact lens secondary to eyelid malformation
- Severe Ocular surface Disease with keratinization
See the full eligibility criteria
- Adults patients
- Able to give an informed consent
- Capable of being followed during the study
- Candidate for the Boston keratoprosthesis type I
- Patients younger than 18 years old or older than 80 years old
- Unable to give an informed consent
- Participating to another treatment glaucoma study
- Patients who received a glaucoma surgery or procedure (glaucoma drainage device or TS-CPC treatment) 3 months before their initial visit.
- Unable to wear a therapeutic contact lens secondary to eyelid malformation
- Severe Ocular surface Disease with keratinization
- Intra-ocular tumor
- Terminal Glaucoma
- Phthisis bulbi
- Ocular albinism
The study team makes the final eligibility decision.
Where it's taking place
- Montreal, Quebec, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Montreal, Quebec, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.